Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing reverse remodeling effects of Entresto using echocardiography endocardial surface analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entresto (sacubitril/valsartan)

Snippet

Sponsor: University of Chicago | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-01-29